Investing.com - Pyxis Oncology (NASDAQ: PYXS) reported first quarter EPS of $-0.060, $0.16 better than the analyst estimate of $-0.221. Revenue for the quarter came in at $16.15M versus the consensus estimate of $3.3M.
Pyxis Oncology's stock price closed at $4.29. It is down -21.280% in the last 3 months and up 11.660% in the last 12 months.
Pyxis Oncology saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Pyxis Oncology's stock price’s past reactions to earnings here.
According to InvestingPro, Pyxis Oncology's Financial Health score is "fair performance".
Check out Pyxis Oncology's recent earnings performance, and Pyxis Oncology's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar